연구성과로 돌아가기

2021 연구자 정보 (339 / 1146)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Lee, C. K.
(Lee, CK) ⓘ 		Kyung Hee Univ, Coll Med, Gastroenterol, Seoul, South Korea
NVIDIA, Santa Clara, CA 95051 USA ⓘ 		AAI-1012-2020
Lee, Chang ⓘ
ⓘ 		[JCR상위 12.4] Clinical outcomes of vedolizumab maintenance treatment for Korean patients with inflammatory bowel disease who failed anti-TNF therapy: A KASID prospective multicenter cohort study
[JCR상위 0.2] Federated learning for predicting clinical outcomes in patients with COVID-19 ⓘ 		SCIE ⓘ 0.2 GASTROENTEROLOGY & HEPATOLOGY
BIOCHEMISTRY & MOLECULAR BIOLOGY;CELL BIOLOGY;MEDICINE, RESEARCH & EXPERIMENTAL ⓘ 		mflores@nvidia.com; ⓘ
Lee, J. H.
(Lee, JH) ⓘ 		Seoul Song Do Colorectal Hosp, Digest Endoscop Ctr, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 12.4] Comparison of the pharmacokinetics of CT-P13 between Crohn's Disease and Ulcerative Colitis in biologic-naive patients; a prospective multi-center observational study of the KASID ⓘ SCIE ⓘ 12.4 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Lee, K. M.
(Lee, KM) ⓘ 		Catholic Univ Korea, St Vincents Hosp, Coll Med, Internal Med, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 12.4] Clinical outcomes of vedolizumab maintenance treatment for Korean patients with inflammatory bowel disease who failed anti-TNF therapy: A KASID prospective multicenter cohort study ⓘ SCIE ⓘ 12.4 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Lee, Y. J.
(Lee, YJ) ⓘ 		Keimyung Univ, Sch Med, Internal Med, Daegu, South Korea ⓘ AAB-9799-2022
Lee, Yoojin ⓘ
ⓘ 		[JCR상위 12.4] Comparison of the pharmacokinetics of CT-P13 between Crohn's Disease and Ulcerative Colitis in biologic-naive patients; a prospective multi-center observational study of the KASID ⓘ SCIE ⓘ 12.4 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Legnani, P.
(Legnani, P) ⓘ 		Icahn Sch Med Mt Sinai, Henry D Janowitz Div Gastroenterol, New York, NY 10029 USA ⓘ
ⓘ
ⓘ 		[JCR상위 12.4] Intestinal inflammation and microbiome diversity are conserved more in consecutive pregnancies among women with inflammatory bowel disease compared to healthy controls ⓘ SCIE ⓘ 12.4 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Maser, E.
(Maser, E) ⓘ 		Icahn Sch Med Mt Sinai, Henry D Janowitz Div Gastroenterol, New York, NY 10029 USA ⓘ
ⓘ
ⓘ 		[JCR상위 12.4] Intestinal inflammation and microbiome diversity are conserved more in consecutive pregnancies among women with inflammatory bowel disease compared to healthy controls ⓘ SCIE ⓘ 12.4 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Mork, E.
(Mork, E) ⓘ 		Calpro AS, Lysaker, Norway ⓘ
ⓘ
ⓘ 		[JCR상위 12.4] Intestinal inflammation and microbiome diversity are conserved more in consecutive pregnancies among women with inflammatory bowel disease compared to healthy controls ⓘ SCIE ⓘ 12.4 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Na, S. Y.
(Na, SY) ⓘ 		Catholic Univ Korea, Incheon St Marys Hosp, Internal Med, Coll Med, Incheon, South Korea ⓘ AAG-4341-2021
Kwak, Sang Gyu ⓘ
ⓘ 		[JCR상위 12.4] Real-life effectiveness and safety of tofacitinib treatment in patients with ulcerative colitis: A KASID multicenter cohort study ⓘ SCIE ⓘ 12.4 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Oh, K.
(Oh, K) ⓘ 		제1저자 Univ Ulsan, Coll Med, Asan Med Ctr, Gastroenterol, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 12.4] Real-life effectiveness and safety of tofacitinib treatment in patients with ulcerative colitis: A KASID multicenter cohort study
[JCR상위 12.4] Clinical outcomes of vedolizumab maintenance treatment for Korean patients with inflammatory bowel disease who failed anti-TNF therapy: A KASID prospective multicenter cohort study ⓘ 		SCIE ⓘ 12.4 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Park, D. I.
(Park, DI) ⓘ 		Sungkyunkwan Univ, Sch Med, Internal Med, Seoul, South Korea
Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Internal Med, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 12.4] Comparison of the pharmacokinetics of CT-P13 between Crohn's Disease and Ulcerative Colitis in biologic-naive patients; a prospective multi-center observational study of the KASID
[JCR상위 12.4] Clinical outcomes of vedolizumab maintenance treatment for Korean patients with inflammatory bowel disease who failed anti-TNF therapy: A KASID prospective multicenter cohort study ⓘ 		SCIE ⓘ 12.4 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Park, S. J.
(Park, SJ) ⓘ 		Yonsei Univ, Coll Med, Severance Hosp, Internal Med, Seoul, South Korea
Yonsei Univ, Coll Med, Severance Hosp, Inst Gastroenterol, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 12.4] Clinical outcomes of vedolizumab maintenance treatment for Korean patients with inflammatory bowel disease who failed anti-TNF therapy: A KASID prospective multicenter cohort study ⓘ SCIE ⓘ 12.4 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Park, Y. S.
(Park, YS) ⓘ 		Eulji Univ, Sch Med, Eulji Hosp, Internal Med, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 12.4] Comparison of the pharmacokinetics of CT-P13 between Crohn's Disease and Ulcerative Colitis in biologic-naive patients; a prospective multi-center observational study of the KASID ⓘ SCIE ⓘ 12.4 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Peter, I.
(Peter, I) ⓘ 		Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA ⓘ
ⓘ
ⓘ 		[JCR상위 12.4] Intestinal inflammation and microbiome diversity are conserved more in consecutive pregnancies among women with inflammatory bowel disease compared to healthy controls ⓘ SCIE ⓘ 12.4 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Rendon, A.
(Rendon, A) ⓘ 		Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA ⓘ
ⓘ
ⓘ 		[JCR상위 12.4] Intestinal inflammation and microbiome diversity are conserved more in consecutive pregnancies among women with inflammatory bowel disease compared to healthy controls ⓘ SCIE ⓘ 12.4 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Sabino, J.
(Sabino, J) ⓘ 		Icahn Sch Med Mt Sinai, Henry D Janowitz Div Gastroenterol, New York, NY 10029 USA
Univ Hosp Leuven, Div Gastroenterol, Leuven, Belgium ⓘ 		L-1093-2019
Sabino, João ⓘ
ⓘ 		[JCR상위 12.4] Intestinal inflammation and microbiome diversity are conserved more in consecutive pregnancies among women with inflammatory bowel disease compared to healthy controls ⓘ SCIE ⓘ 12.4 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
페이지 이동: